This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rascle, A. Articles by Samarut, J. Search for Related Content PubMed PubMed Citation Articles by Rascle, A. Articles by Samarut, J.

 Previous Article  |  Next Article 

Mol. Cell. Biol., Nov 1996, 6338-6351, Vol 16, No. 11
Copyright © 1996, American Society for Microbiology

Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus

A Rascle, N Ferrand, O Gandrillon and J Samarut
Laboratoire de Biologie Moleculaire et Cellulaire de l'Ecole Normale Superieure de Lyon, UMR49 CNRS, France.

The E26 and avian erythroblastosis virus (AEV) avian retroviruses induce acute leukemia in chickens. E26 can block both erythroid and myeloid differentiation at an early multipotent stage. Moreover, E26 can block erythroid differentiation at the erythroid burst-forming unit/erythroid CFU (BFU-E/CFU-E) stage, which also corresponds to the differentiation stage blocked by AEV. AEV carries two oncogenes, v-erbA and v-erbB, whereas E26 encodes a single 135-kDa Gag-Myb-Ets fusion oncoprotein. v-ErbA is responsible for the erythroid differentiation arrest through negative interferences with both the retinoic acid receptor (RAR) and the thyroid hormone receptor (T3R/c-ErbA). We investigated whether Myb-Ets could block erythroid differentiation in a manner similar to v-ErbA. We show here that Myb-Ets inhibits both RAR and c-ErbA activities on specific hormone response elements in transient-expression assays. Moreover, Myb-Ets abrogates the inactivation of transcription factor AP-1 by RAR and T3R, another feature shared with v-ErbA. Myb-Ets also antagonizes the biological response of erythrocytic progenitor cells to retinoic acid and T3. Analysis of a series of mutants of Myb-Ets reveals that the domains of the oncoprotein involved in these inhibitory activities are the same as those involved in oncogenic transformation of hematopoietic cells. These data demonstrate that the Myb-Ets oncoprotein shares properties with the v-ErbA oncoprotein and that inhibition of ligand-dependent RAR and c-ErbA functions by Myb-Ets is responsible for blocking the differentiation of hematopoietic progenitors.

This article has been cited by other articles:

• Dahl, R., Kieslinger, M., Beug, H., Hayman, M. J. (1998). Transformation of hematopoietic cells by the Ski oncoprotein involves repression of retinoic acid receptor signaling. Proc. Natl. Acad. Sci. USA 95: 11187-11192 [Abstract] [Full Text]  
• Pfitzner, E., Kirfel, J., Becker, P., Rolke, A., Schule, R. (1998). Physical interaction between retinoic acid receptor and the oncoprotein Myb inhibits retinoic acid-dependent transactivation. Proc. Natl. Acad. Sci. USA 95: 5539-5544 [Abstract] [Full Text]  
• Yang, C., Shapiro, L. H., Rivera, M., Kumar, A., Brindle, P. K. (1998). A Role for CREB Binding Protein and p300 Transcriptional Coactivators in Ets-1 Transactivation Functions. Mol. Cell. Biol. 18: 2218-2229 [Abstract] [Full Text]  
• Chassande, O., Fraichard, A., Gauthier, K., Flamant, F., Legrand, C., Savatier, P., Laudet, V., Samarut, J. (1997). Identification of Transcripts Initiated from an Internal Promoter in the c-erbA{alpha} Locus That Encode Inhibitors of Retinoic Acid Receptor-{alpha} and Triiodothyronine Receptor Activities. Mol. Endocrinol. 11: 1278-1290 [Abstract] [Full Text]